Home Tags United States

Tag: United States

Why ‘one day at a time’ works for recovering alcoholics

8/27/20--"One day at a time” is a mantra for recovering alcoholics, for whom each day without a drink builds the strength to go on to the next. A new brain imaging study by Yale researchers shows why the approach works. Read

Look beyond opioids to solve national substance use epidemic

8/28/20--A new study published reveals that three-quarters of participants in an inpatient addiction intervention program came into the hospital using more than one substance. The findings suggests that a singular focus on opioids may do more harm than good if doctors overlook the complexity of each individual's actual substance use. Read

Cannabis and synthetic cannabinoid poison control center cases among adults aged 50+, 2009–2019

8/25/20--A study used the American Association of Poison Control Centers’ National Poison Data System (NPDS), January 1, 2009–December 31, 2019, to examine 5201 cases aged 50+ in which cannabis was the only or primary substance. Although poison control center (PCC) cannabis cases involving older adults are relatively few, cases of other cannabis preparations than plant forms increased rapidly in recent years while cases of synthetic cannabinoids decreased. The rate of major medical outcomes also appears to be high. Read

Pediatric cannabis poisonings in France: more and more frequent and severe

8/25/20--Accidental pediatric cannabis poisonings are an incidental effect of cannabis use. The average THC content of cannabis resin and the number of consumers are rising sharply in the USA and in most European countries. The results of a study with an objective is to examine the evolution of prevalence and severity of pediatric exposures to cannabis in France indicates a significant increase in the number of cases of pediatric exposure to cannabis and a rise in the seriousness of poisonings between 2010 and 2017. Read

Like CBD, but better

8/29/20--A few start-ups and niche firms are developing small molecules that are inspired by CBD and other natural products from cannabis plants as potential drugs for a wide array of diseases. Human clinical trials are underway or just wrapping up for some of these drug candidates, while others are still in research or preclinical stages. Read

Cannabis ballot measures finalized, Florida gets edibles, capital raises rebounding & more

8/29/20--A recreational marijuana legalization ballot measure in Arizona got the final go-ahead, while a medical cannabis legalization initiative in Nebraska is fighting to keep its place on the November ballot. And, the addition of edibles to Florida’s medical marijuana market became formal under state health department rules. Read

Hemp Opportunity Zone Act

9/1/20-- Introducing the bill to amend the Internal Revenue code of 1986 to establish Hemp Opportunity Zones. Among other things, Section Six calls for a study to determine if 0.3% THC in hemp is adequate of if the limit should be moved up to 1% THC. Read
 

The case against legalization and decriminalization of marijuana

8/24/20--In an editorial published in the Washington Examiner written by Kyle Reynolds, an Indiana University correspondent for Campus Reform, he candidly expresses his views on how disconcerting it is that the Democratic Party is moving with such force to decriminalize and legalize marijuana. Read

Tell your representative to oppose the MORE Act

9/1/20--Big Pot is pushing hard for Congress to hold a full vote on the MORE Act, a bill to federally legalize and commercialize marijuana under the auspices of social justice. SAM is urging the public to tell representatives in Congress that moving the MORE Act is unacceptable. Read

FDA should require research on impact of e-cigarettes and other tobacco products on youth before authorizing marketing of tobacco products and claims of modified risk

7/23/20--In a new commentary published in the Journal of Adolescent Health, a group of leading tobacco control experts called on the U.S. Food and Drug Administration (FDA) to require tobacco companies to submit research showing the impact on youth and young adults in the United States before authorizing the marketing of any new tobacco product, including e-cigarettes, or permitting any claim that states or implies a tobacco product is less harmful than any other tobacco product. Read

Juul submits application to FDA to keep selling e-cigarettes

7/30/20--Juul Labs Inc submitted an application to the U.S. Food and Drug Administration that would allow it to keep selling e-cigarettes, which face heightened scrutiny over a surge in teenage vaping. Once an application is submitted, companies can keep selling their products for a year from the date of deadline, without official approval, or until a negative action is taken by the FDA. Read

Juul quietly revamped its e-cigarette, risking the FDA’s rebuke

7/23/20--According to four former Juul employees, the company’s engineers changed the pod design, added new, heartier internal components to resist the shutdown problem, and rewrote the device’s firmware. The updated model, delivered in late 2017, was given the internal code name Jagwar. Federal regulators were similarly unaware of the full extent of the product changes, even as the Food and Drug Administration crawled all over the company for months in an effort to curb a widening youth nicotine epidemic. Read
 

Kids These Days: Vaping comes with consequences. So why do teens do it?

7/29/20--There can be serious consequences to vaping, so why do so many teens continue to do it? In this episode, Grace Wang and Mia Goldstein talk to teens about addiction. Read

Sweet coolers a gateway to increased alcohol consumption

7/22/20--Based on the first study to look at the role of high-fructose corn syrup - the main ingredient in most coolers - a University of Guelph professor suggests that these sweetened beverages can actually promote harmful alcohol consumption, according to University of Guelph psychology professor Francesco Leri. Read

The Tobacco Prevention Toolkit

7/31/20--Theory-based and evidence-informed resources created by educators, parents, and researchers aimed at preventing middle and high school students’ use of tobacco and nicotine. Read

“False and Misleading:” Suit claims select vapes contain less THC than labelled

7/31/20--A new class action lawsuit against Oregon cannabis company Cura CS LLC seeks more than $10M over claims that its Select Elite vape cartridges contained much less THC than labeled. Read

FDA approves new indication for drug containing an active ingredient derived from cannabis to treat seizures in rare genetic disease

7/31/20--The U.S. Food and Drug Administration approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older. Epidiolex was previously approved for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS). Read

Self-reported cannabis use and biomarkers of inflammation among adults in the United States

8/15/20--Data from this nationally representative study suggest potential anti-inflammatory effects of recent cannabis use. Additional studies that biologically measure the THC and CBD concentrations of the cannabis used and employ prospective and or experimental study designs investigate cannabis and inflammation associations are needed. Read

Characteristics of marijuana use during pregnancy — Eight states, pregnancy risk assessment monitoring system, 2017

8/14/20--Continuous surveillance of marijuana use in the perinatal period can inform clinical guidance, provider and patient education, and public health programs to support evidence-based approaches to addressing substance use. Yet, the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics recommend refraining from marijuana use during pregnancy and lactation because evidence on safety and health effects are inconclusive or insufficient. Read

Court Denies DEA’s attempt to dismiss medical marijuana case

8/21/20--On Tuesday, the Ninth Circuit filed a one-page order denying the United States Drug Enforcement Administration (DEA)’s motion to dismiss in a lawsuit in which the Scottsdale Research Institute and its president, Dr. Suzanne Sisley, are attempting to reschedule medical marijuana. Read

Marijuana Regulatory Agency recalls contaminated pre-rolls, suspends processor licenses pending investigation

8/6/20--The Marijuana Regulatory Agency (MRA) issued a public health and safety bulletin today, notifying the public of a marijuana product recall of contaminated “pre-rolls” from retail outlets located in Bay City, Hazel Park, Detroit, Traverse City, Ann Arbor, Lansing, River Rouge, Ferndale, Quincy, Lowell, Negaunee, and Lapeer. In addition, the MRA stipulated and agreed to a 14-day suspension of the medical and adult-use processor licenses of 3843 Euclid LLC in Bay City, pending further MRA investigation. Read

Mass. regulators fine Revolutionary Clinics $120,000 for selling tainted marijuana vapes

8/6/20--A Fitchburg marijuana company, Revolutionary Clinics, will pay Massachusetts $120,000 to settle charges it sold vaporizers containing excessive levels of ethanol to six other dispensaries, which then sold dozens of the tainted devices to consumers. The Cannabis Control Commission voted unanimously to approve the fine and impose a four-month probation for the company over various violations related to the wholesale vape transactions, which occurred from December 2018 to early 2019. Read

The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation

8/7/20--In this study, scientists aimed to overview the recent available literature regarding in vivo potential of natural and synthetic cannabinoids with underlying mechanisms of action for protecting against cognitive decline and motor impairments. Read

Assessment of menthol and nonmenthol cigarette consumption in the US, 2000 to 2018

8/7/20--This serial cross-sectional study estimates menthol and nonmenthol cigarette consumption from 2000 to 2018 with a previously used approach. Results indicate that the large decline in cigarette consumption in the US over the last 2 decades is overwhelmingly attributed to nonmenthol cigarettes, and this trend is more pronounced since the signing of the TCA. Read

European group: E-cigarette use should be limited due to CV effects

8/6/20--In a new position paper, the European Association of Preventive Cardiology recommended that due to known CV harms from e-cigarettes, they should not be used for smoking cessation except as a last resort. Read

Clearing the smoke on cannabis

8/7/20--This is the fourth in a series of reports that reviews the effects of cannabis use on various aspects of human functioning and development. This report on the respiratory and cardiovascular effects of cannabis smoking provides an update of a previous report with new research findings that validate and extend our current understanding of this issue. Read

Mass regulators release 619,000 aging marijuana vapes for sale, despite lead contamination concerns

8/7/20--Consumers in Massachusetts may soon notice an unfamiliar warning sticker on their marijuana vapes: “This product was previously quarantined. Passed retesting for heavy metals and Vitamin E Acetate.” Actually, more than 619,000 vapes were sitting in vaults at cannabis facilities across the state since September, when Governor Charlie Baker temporarily banned the devices in an effort to combat an outbreak of vaping-related lung illnesses. Read

Forecasts hazy for state marijuana revenue

8/10/20--According to a report from The Pew Charitable Trusts, with more states considering legalizing marijuana, forecasting and budgeting difficulties for revenue from recreational marijuana taxes are likely to become widespread. These challenges have consequences: If tax collections come in below forecasted amounts, for example, programs that are funded by these dollars could suffer. Read

American Heart Association warns marijuana is a ‘substantial’ health risk

8/5/20--The American Heart Association has published a new scientific statement warning that cannabis (“marijuana”) is not without health risks — and that some of them may be ‘substantial.’ The advisory comes at a time when a number of states and countries have legalized cannabis to various degrees, offering the opportunity to study the drug and its potential health benefits and downsides. Read

Federal drug decriminalization model unveiled by top reform group

8/10/20--The Drug Policy Alliance (DPA) recently unveiled a framework to federally decriminalize all illicit drugs that they hope will be embraced by Congress. This leading drug policy reform group said ending the drug war will help address racial disparities in the criminal justice system and promote public health. The proposal is being rolled out ahead of the 50th anniversary of the enactment of the Controlled Substances Act, the legislative basis of today’s federal drug criminalization. Read

National Governors Association selects 10 states for data-driven strategies to address impaired driving

8/10/20--As state and local governments adjust to the changing landscape of drug use, the National Governors Association will assist 10 states in developing and executing action plans to improve data collection and standardization efforts related to impaired driving. The states selected are: Colorado, Connecticut, Hawai‘i, Maryland, Minnesota, North Carolina, North Dakota, Vermont, Virginia and Wyoming. Read

Canopy Growth’s new online store provides one-stop shop for growing U.S. product portfolio

7/27/20--Canopy Growth Corporation, a world-leading diversified cannabis, hemp, and cannabis device company, today announced the launch of its new U.S. e-commerce website that will serves as the online home for Canopy Growth’s growing portfolio of U.S. hempderived CBD product lines, and a one-stop shop for over 25 products. Read

Cannabinoids may affect activity of other pharmaceuticals

8/3/20--Cannabinoid-containing products may alter the effects of some prescription drugs, according to Penn State College of Medicine researchers. They published information that could help medical professionals make safe prescribing choices for their patients who use prescription, over-the-counter or illicit cannabinoid products. Read

Marijuana may hurt heart, more research needed, report finds

8/5/20--Marijuana use could hurt the heart and blood vessels, according to a report that found no cardiovascular benefits to cannabis use and called for more research of the drug that is growing in popularity. Observational studies have linked the chemicals in marijuana to an increased risk of heart attacks, heart failure and a heart rhythm disorder called atrial fibrillation, according to the report. Read

The Current Status of Psychedelics in Psychiatry

7/29/20--Until very recently, no companies would manufacture medical-grade psychedelics, which made getting regulatory approval for clinical research—especially clinical trials—very difficult and in some countries (eg, Germany) impossible. Read

Cannabidiol for the treatment of cannabis use disorder

7/28/20--In the first randomised clinical trial of cannabidiol for cannabis use disorder, cannabidiol 400 mg and 800 mg were safe and more efficacious than placebo at reducing cannabis use. Read

Occupational Exposure to Particulate Matter and Volatile Organic Compounds in Two Indoor Cannabis Production Facilities

7/22/20--In this current study, occupational exposures to particulate matter (PM) and volatile organic compounds (VOCs) in various task zones of two indoor cannabis facilities in Washington State were quantified. The observations from this study can help inform the employer of the task zones where exposure to respiratory hazards are the highest, and where it may be beneficial to deploy control measures to reduce worker exposures. Read

In shadow of pandemic, U.S. drug overdose deaths resurge to record

7/15/20--Drug deaths in America, which fell for the first time in 25 years in 2018, rose to record numbers in 2019 and are continuing to climb, a resurgence that is being complicated and perhaps worsened by the coronavirus pandemic. Read

FDA issues draft guidance on cannabis research

7/22/20--The Food and Drug Administration yesterday issued draft guidance for cannabis researchers. It is “limited to the development of human drugs and does not cover other FDA-regulated products.” Read

A Systematic Review with Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease

7/20/20--A number of studies have investigated the effectiveness  for treatment of inflammatory bowel diseases (IBD). This study aimed to systematically analyze the effect of cannabis or cannabinoids in the treatment of inflammatory bowel diseases (IBD) patients. Results indicate that Cannabi(noid)s do not induce clinical remission or affect inflammation in IBD patients. However, cannabi(noid)s significantly improve patient-reported symptoms and QoL. Read

Traditional PTSD therapy doesn’t trigger drug relapse

7/20/20--Researchers have now demonstrated that behavior therapy that exposes people to memories of their trauma doesn't cause relapses of opioid or other drug use, and that PTSD severity and emotional problems have decreased after the first therapy session. Read

Content Analysis of Instagram Posts From 2019 With Cartoon-Based Marketing of e-Cigarette–Associated Products

7/20/20--Studies have indicated that cartoons are an effective strategy in increasing product recognition and susceptibility to use e-cigarettes. Recently, the US Food and Drug Administration announced it is prioritizing enforcement against e-cigarette companies that use marketing likely to promote youth use. This study aimed to determine if companies were using cartoon-based strategies to market and promote e-cigarette–associated products in 2019 on Instagram. Read

PANDA: The Birth of a Pan-American Drug-User Alliance

7/20/20--Representatives from some leading drug user-led, community-based groups have recently been meeting online to work collectively against the cycle of drug-war oppression and death. Pan-American Network of Drug-user Activists—PANDA—was created to abolish prohibition. Read

Midwestern Hemp Database Project seeks grower participation

7/16/20--The goal of this project is to provide regional (Illinois, Indiana, Wisconsin and Michigan) insight into agronomic performance and cannabinoid development of modern hemp varieties. This project will rely heavily on dedicated grower cooperation to provide useful information to experienced and new growers interested hemp production. Read

Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review

9/1/20--The evidence found in this study indicates that CBD is a promising adjunct therapy for the treatment of cocaine dependence due to its effect on: cocaine reward effects, cocaine consumption, behavioral responses, anxiety, neuronal proliferation, hepatic protection and safety. Moreover, clinical trials are strongly required to determine whether the findings in animal models occur in humans diagnosed for cocaine or crack cocaine use disorder. Read

Controversial e-cigarette company Puff Bar says it’s suspending U.S. sales

7/13/20--Puff Bar, a California-based marketer of disposable e-cigarettes, announced the sales suspension Monday on its website. In a phone call with FairWarning, the company’s Chief Financial Officer Patrick Beltran confirmed that U.S. sales were being halted until further notice, but said that international sales would continue for the time being. Beltran would not give a reason for the move. Read

Effect of inhaled cannabis for pain in adults with sickle cell disease a randomized clinical trial

7/17/20-- This randomized clinical trial found that, compared with vaporized placebo, vaporized cannabis did not statistically significantly reduce pain and associated symptoms, except interference in mood, in patients with SCD with chronic pain. Read

States allow misleading claims that cannabis can treat opioid addiction

7/15/20--Though there's no evidence that cannabis can treat opioid use disorder, medical boards in four states -- Pennsylvania, New York, New Jersey and New Mexico -- include the disorder among conditions that qualify a person to access marijuana for medical purposes. Shover and her colleagues found that in the Northeastern states where that is the case, more dispensaries make advertising claims that cannabis can treat opioid addiction than they do in adjacent states. Read

Association of state policies allowing medical cannabis for opioid use disorder with dispensary marketing for this indication

7/14/20--According to this study, state-level policies designating opioid use disorder (OUD) as a qualifying condition for medical cannabis were associated with more dispensaries claiming cannabis can treat OUD. Future studies linking dispensary advertisements to health outcomes in people with OUD (eg, use of MOUDs, overdose mortality) are warranted, as are investigations into advertising that addresses other conditions with major morbidity and mortality consequences. Read

Reducing vaping among youth and young adults

7/1/20--This guide supports health care providers, systems, and communities seeking to prevent vaping. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources. Read

Commend Biden for resisting Big Marijuana | opinion

7/14/20--The Biden-Sanders joint presidential task force recently issued recommendations for a unity platform to move forward on a number of hot button issues. Among them: marijuana legalization, which the task force notably chose not to endorse, siding instead with decriminalization and research. Several commentators—from publications like National Review to The Atlantic and The Nation—chided Biden for not endorsing pot. But, according to a Newsweek op-ed by president and CEO of Smart Approaches to Marijuana Kevin Sabet, the former vice president should be commended for siding with science, not politics. Read

You know what else has sold well during the pandemic? Weed edibles

7/13/20--Pandemic anxiety and mounting concerns about vaping have contributed to the increase of cannabis product sales. Since March, the cannabis industry has seen an influx of new customers, and as fear of inhaled products has risen — spurred partly by studies of “vaping illness” and exacerbated by respiratory risks associated with the coronavirus — many consumers have opted to enjoy cannabis in edible form. Read

Cannabis use among US adults with anxiety from 2008 to 2017: The role of state-level cannabis legalization

9/1/20--According to study results, cannabis use is increasing among American adults overall, yet is disproportionately common among Americans with anxiety especially among those residing in states where cannabis has been legalized. Read

SEC files charges in $25 million cannabis-related offering fraud

7/29/20--The Securities and Exchange Commission today announced charges against six individuals and their companies for defrauding investors in connection with unregistered securities offerings that raised over $25 million. Read

Novel Insights on Cannabis and Psychosis

7/28/20--There is evidence in both patients with psychotic disorders and the general population that cannabis use is associated with adverse effects of psychopathology and cognition. Read

LaMalfa leads bipartisan group of lawmakers in introducing bill to eradicate illegal marijuana grows on public lands

7/9/20--Congressman Doug LaMalfa issued the following statement after he and Rep. Jared Huffman, Rep. Doug Lamborn, Rep. Salud Carbajal, Rep. Hal Rogers, and Rep. TJ Cox introduced the Protecting Lands Against Narcotics Trafficking (PLANT) Act. This legislation provides resources to help local, state, and federal law enforcement eradicate illegal marijuana grows on public lands and establishes a fund to restore land that has been damaged by illegal cultivation activities. Read

FTC order stops the marketer of “Thrive” supplement from making baseless claims it can treat, prevent, or reduce the risks from COVID-19

7/10/20--The California-based marketer of a supplement called Thrive, which consists mainly of Vitamin C and herbal extracts, is barred from continuing to make baseless claims that it can treat, prevent, or reduce the risk of COVID-19, under an administrative settlement with the Federal Trade Commission announced today. Read

Increasing popularity of 7/10 exemplifies rise in cannabis concentrates

7/10/20--July 10, also known as 710 or Oil Day, is the cannabis industry’s second annual “holiday.” Although not as popular or as well celebrated as 4/20, July 10 has picked up steam in recent years due to the rising popularity of concentrated cannabis products. Read

CBD may be legal, but challenges still persist in obtaining CBD product trademark registration

7/7/20--Last week, the Trademark Trial and Appeal Board (TTAB) ruled that a Colorado Cannabidiol (CBD) company could not register a trademark for hemp oil extracts because it violated the Food, Drug & Cosmetics Act (FDCA). Trademark registrations associated with cannabis have repeatedly been refused because they cannot be “lawfully used in commerce." Read

Drug overdoses: The hidden epidemic in the pandemic

7/5/20--Suspected cases of drug overdoses soared between March and May, according to data from medical teams,hospitals and the police. According to a Washington Post report, the isolation and economic upheaval caused by the pandemic are fueling this hidden epidemic. Heather Long who co-wrote that story joins Hari Sreenivasan to discuss. Read